Clinical Trial Update: Effects of Transdermal Testosterone and/or Monthly Vitamin D on Fall Risk in Pre--frail Hypogonadal Seniors [Phase 3]

View source ↗

Summary

Phase 3 trial update on transdermal testosterone and/or monthly vitamin D and their effect on fall risk in pre-frail hypogonadal seniors; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falls Risk in Older Adults
• Frailty in Elderly
• Hypogonadism

Drugs mentioned

• Transdermal Testosterone (testosterone)
• monthly vitamin D (vitamin D)

Snippet

Sponsor: University of Zurich | Conditions: Hypogonadism, Pre-frail Seniors | Phase 3 | Status: TERMINATED